GE HealthCare Technologies Inc. $GEHC Shares Sold by Intech Investment Management LLC

Intech Investment Management LLC lessened its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 5.7% during the 1st quarter, Holdings Channel.com reports. The fund owned 294,229 shares of the company’s stock after selling 17,851 shares during the period. Intech Investment Management LLC’s holdings in GE HealthCare Technologies were worth $23,747,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Hotchkis & Wiley Capital Management LLC raised its position in GE HealthCare Technologies by 3.2% during the first quarter. Hotchkis & Wiley Capital Management LLC now owns 5,751,773 shares of the company’s stock valued at $464,226,000 after buying an additional 176,572 shares during the period. JPMorgan Chase & Co. raised its holdings in shares of GE HealthCare Technologies by 49.9% in the first quarter. JPMorgan Chase & Co. now owns 5,140,549 shares of the company’s stock valued at $414,894,000 after purchasing an additional 1,711,963 shares during the last quarter. Dimensional Fund Advisors LP lifted its position in shares of GE HealthCare Technologies by 3.3% in the first quarter. Dimensional Fund Advisors LP now owns 4,943,579 shares of the company’s stock valued at $398,975,000 after buying an additional 157,839 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its stake in GE HealthCare Technologies by 14.3% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 3,325,096 shares of the company’s stock worth $259,956,000 after acquiring an additional 416,386 shares during the period. Finally, Canada Pension Plan Investment Board increased its stake in shares of GE HealthCare Technologies by 15.2% in the first quarter. Canada Pension Plan Investment Board now owns 3,111,398 shares of the company’s stock valued at $251,121,000 after buying an additional 409,636 shares during the period. 82.06% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research firms have recently issued reports on GEHC. BTIG Research reissued a “buy” rating on shares of GE HealthCare Technologies in a research report on Monday, July 14th. Citigroup upped their price target on shares of GE HealthCare Technologies from $89.00 to $93.00 and gave the company a “buy” rating in a research report on Thursday, July 31st. Zacks Research raised shares of GE HealthCare Technologies from a “hold” rating to a “strong-buy” rating in a research note on Thursday, August 28th. Morgan Stanley cut their price target on shares of GE HealthCare Technologies from $78.00 to $74.00 and set an “equal weight” rating on the stock in a report on Thursday, July 31st. Finally, Wall Street Zen raised GE HealthCare Technologies from a “hold” rating to a “buy” rating in a research note on Saturday, May 31st. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $88.40.

GE HealthCare Technologies Stock Performance

Shares of GEHC opened at $78.71 on Wednesday. The company has a market cap of $35.94 billion, a price-to-earnings ratio of 16.13, a price-to-earnings-growth ratio of 2.99 and a beta of 1.13. The company has a debt-to-equity ratio of 0.85, a quick ratio of 0.93 and a current ratio of 1.16. The firm has a fifty day moving average of $74.42 and a 200-day moving average of $73.83. GE HealthCare Technologies Inc. has a 1 year low of $57.65 and a 1 year high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings data on Wednesday, July 30th. The company reported $1.06 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.91 by $0.15. GE HealthCare Technologies had a return on equity of 23.93% and a net margin of 11.22%.The business had revenue of $5 billion during the quarter, compared to analyst estimates of $4.96 billion. During the same period last year, the company earned $1.00 earnings per share. GE HealthCare Technologies’s quarterly revenue was up 3.5% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. As a group, equities analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, August 15th. Investors of record on Friday, July 25th were given a $0.035 dividend. The ex-dividend date of this dividend was Friday, July 25th. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. GE HealthCare Technologies’s payout ratio is currently 2.87%.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.